ArticleP & T : a peer-reviewed journal for formulary management2015
Pharmacological Treatment of Insomnia.
Article in P & T : a peer-reviewed journal for formulary management, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 4 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- The Effectiveness of Acupressure on Sleep Quality in Cancer Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.Journal of clinical nursing · 2025Pooled it
- Factors impacting prazosin efficacy for nightmares and insomnia in PTSD patients - a systematic review and meta-regression analysis.Progress in neuro-psychopharmacology & biological psychiatry · 2025Pooled it
- Toxicity of benzodiazepines in the treatment of insomnia disorders in older adults: a systematic literature review.Croatian medical journal · 2024Pooled it
- Effects of physical activity programs on sleep outcomes in older adults: a systematic review.The international journal of behavioral nutrition and physical activity · 2020Pooled it
- Efficacy of electrical vestibular stimulation (VeNS) on adults with insomnia: A double-blind, randomized, sham-controlled trial.Dialogues in clinical neuroscience · 2025Trial
- SleepNow - A combined cognitive behavioral therapy for insomnia and physical exercise intervention in men with metastatic prostate cancer: results from a feasibility randomized controlled trial.Acta oncologica (Stockholm, Sweden) · 2025Trial
- Trial
- Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2020Trial
- A Randomized, Triple-Blind, Placebo-Controlled, Parallel Clinical Trial Investigating Safety and Efficacy of Corn Leaf Extract on Sleep Quality in a Healthy Population With Difficulty Falling or Staying Asleep.Food science & nutrition · 2026Article
- Orexin receptor antagonists attenuate acute stress-induced disruptions in sleep states.Frontiers in neuroscience · 2026Article
- An exploratory randomized controlled trial protocol evaluating Cognitive Behavioral Therapy for Insomnia with adjunct Ayurvedic external therapies (Frontiers in medicine · 2026Article
- Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders.CNS drugs · 2025Review
- A case report: Treating insomnia with olanzapine in cancer patients.Palliative & supportive care · 2025Article
- A Dual Nanoapproach for the Treatment of Depression and Sleep Via a Novel Optimized Eugenol-Mucoadhesive Nanoemulsion.ACS omega · 2025Article
- Novel murine closed-loop auditory stimulation paradigm elicits macrostructural sleep benefits in neurodegeneration.Journal of sleep research · 2025Article
- Effectiveness of anFood science & nutrition · 2025Article
- Article
- Glycemic status and macronutrient intake as predictors of sleep outcomes: an analysis of NHANES 2007-2020 data.Frontiers in nutrition · 2025Article
- Long-term neurological consequences following benzodiazepine exposure: A scoping review.PloS one · 2025Article
- Use of mHealth Technologies to Increase Sleep Quality among Older Adults: A Scoping Review.Clocks & sleep · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Up to 70 million U.S. adults have chronic sleep and wakefulness disorders. Therapies may include prescription medications approved by the Food and Drug Administration, off-label treatments, over-the-counter drugs, and herbal therapies.
Identifiers
26609210PMC4634348W2174409919What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.